Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry.
Research in Action Awards 2025
Save the Date: Monday, October 20, 2025 , when our Research in Action Awards return this fall! We'll honor some of the most brilliant activists, scientists, and leaders in the fight to end HIV, tuberculosis (TB), and hepatitis C (HCV). And until July 1, get tickets at our special-early bird rate!
Story: HIV cure “breakthrough” with mRNA-delivered Tat protein
June 2025 Media coverage: Breakthrough in search for HIV cure leaves researchers ‘overwhelmed’ - Kat Lay, The Guardian, June 5, 2025 Major breakthrough in battle for HIV cure ‘previously thought impossible’ - Athena Stavrou, Independent, June 5, 2025 Used in…
Treatment Action Group Statement on Termination of HIV Vaccine Research Funding
On Friday May 30, it was reported that National Institutes of Health (NIH) leadership has unilaterally terminated funding for HIV vaccine research consortia that were making significant progress toward solving the stern challenge of inducing protective broadly neutralizing antibodies against the virus.
WEBINAR: TB Treatment’s New Frontier: Orienting Community to Long-Acting Injectables for TB
On June 5, 2025, TAG and WHO cohosted a webinar orienting people to long-acting injectables for TB treatment and prevention. Long-acting Injectables (LAIs) have the potential to revolutionize treatment for TB and other infectious diseases.
An Ethical and Legal Crisis: Treatment Action Group (TAG) Statement on the Withholding of NIH Funding for HIV Clinical Research Networks
TAG demands immediate action by the National Institutes of Health (NIH) to provide Congressionally appropriated and committed funding to the HIV clinical research networks (ACTG, HPTN, HVTN, IMPAACT).
2025 Comments Delivered at the WHO Director General’s TB Vaccine Accelerator Council
These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 3rd meeting of the WHO Director-General’s TB Vaccine Accelerator Council on May 20, 2025 in Geneva, Switzerland.
U.S. Funding Cuts Threaten 39 Research Sites in South Africa Putting Scientific Advancements and Hard Won Progress Against TB and HIV at Risk
Lifesaving scientific research on prevention, testing, treatment and care for people living with HIV and tuberculosis (TB) in South Africa is under serious threat due to funding suspensions and grant terminations from the United States (US) government.
South Africa’s TB and HIV Research at Risk: A Call to Catalyze Urgent Action by Funders
Developed by TAG, Médecins Sans Frontières, and the South African Medical Research Council, this issue brief provides information about TB and HIV clinical trials and research programs impacted by U.S. government funding disruptions...
Ways You Can Help TAG
Become a Monthly Donor Become one of our community of dedicated supporters by becoming a monthly donor to TAG. Your recurring contribution provides steady support for critical programs, groundbreaking research, and advocacy efforts to combat HIV, hepatitis C, and tuberculosis…